1 |
|
Early SARS-CoV-2 Infection Events
|
83 |
1.492 |
SuperPathway |
- Early SARS-CoV-2 Infection Events
|
Pathways |
- SARS-CoV-2 Infection
- SARS-CoV-1 Infection
- Early SARS-CoV-2 Infection Events
|
|
2 |
|
Bacterial infections in CF airways
|
97 |
1.330 |
SuperPathway |
- Bacterial infections in CF airways
|
Pathways |
- Bacterial infections in CF airways
- Immune response Bacterial infections in normal airways
|
|
3 |
|
SARS-CoV-2 Infection
|
414 |
1.330 |
SuperPathway |
|
Pathways |
- SARS-CoV Infections
- SARS-CoV-2 Infection
|
|
4 |
|
Influenza Infection
|
157 |
1.119 |
|
5 |
|
Dual hijack model of Vif in HIV infection
|
12 |
1.119 |
SuperPathway |
- Dual hijack model of Vif in HIV infection
|
Pathways |
- Dual hijack model of Vif in HIV infection
|
|
6 |
|
Ebola virus infection in host
|
129 |
1.119 |
SuperPathway |
- Ebola virus infection in host
|
Pathways |
- Ebola virus infection in host
|
|
7 |
|
Latent infection - Other responses of Mtb to phagocytosis
|
1 |
1.119 |
SuperPathway |
- Latent infection - Other responses of Mtb to phagocytosis
|
Pathways |
- Latent infection - Other responses of Mtb to phagocytosis
|
|
8 |
|
Salmonella Infection
|
27 |
1.119 |
|
9 |
|
HCMV Infection
|
160 |
1.119 |
|
10 |
|
ADORA2B mediated anti-inflammatory cytokines production
|
419 |
0.883 |
Pathways |
- Parasitic Infection Pathways
- Leishmania infection
- Anti-inflammatory response favouring Leishmania parasite infection
|
|
11 |
|
HIV Life Cycle
|
231 |
0.721 |
Pathways |
- HIV Infection
- APOBEC3G mediated resistance to HIV-1 infection
|
|
12 |
|
Inflammasomes
|
32 |
0.721 |
Pathways |
- Influenza A virus infection
- Purinergic signaling in leishmaniasis infection
|
|
13 |
|
Toll-like receptor signaling pathway
|
285 |
0.721 |
Pathways |
- Hepatitis B infection
- Measles virus infection
|
|
14 |
|
T-cell activation SARS-CoV-2
|
116 |
0.510 |
Pathways |
- T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection
|
|
15 |
|
Uptake and actions of bacterial toxins
|
73 |
0.510 |
Pathways |
- Bacterial Infection Pathways
|
|
16 |
|
Formation of HIV elongation complex in the absence of HIV Tat
|
180 |
0.510 |
Pathways |
- RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
|
|
17 |
|
Host-pathogen interaction of human coronaviruses - interferon induction
|
52 |
0.510 |
Pathways |
- Type I interferon induction and signaling during SARS-CoV-2 infection
|
|
18 |
|
Development Slit-Robo signaling
|
121 |
0.510 |
Pathways |
- Pathogenic Escherichia coli infection
|
|
19 |
|
SARS-CoV-1-host interactions
|
142 |
0.510 |
|
20 |
|
Translation of Structural Proteins
|
70 |
0.510 |
Pathways |
- Late SARS-CoV-2 Infection Events
|
|
21 |
|
Neuropathic Pain-Signaling in Dorsal Horn Neurons
|
232 |
0.510 |
|
22 |
|
Regulation of actin dynamics for phagocytic cup formation
|
86 |
0.510 |
|
23 |
|
Response of Mtb to phagocytosis
|
27 |
0.510 |
Pathways |
- Infection with Mycobacterium tuberculosis
|
|
24 |
|
Host-pathogen interaction of human corona viruses - ER stress
|
54 |
0.510 |
Pathways |
- Endoplasmic reticulum stress response in coronavirus infection
|
|
25 |
|
Autophagy
|
63 |
0.510 |
Pathways |
- Autophagy during CoV infection
|
|
26 |
|
Infectious disease
|
1747 |
0.510 |
|